Hertility develops personalized reproductive testing and services, including diagnostic testing, egg freezing support, and telemedicine aimed at improving women’s reproductive healthcare. The company was launched in 2019 and is based in the U.K.; it was co-founded by CEO Dr. Helen O’Neill, ovarian biologist Dr. Natalie Getreu, and Deidre O’Neill. Hertility seeks to innovate tools used to research women’s reproductive health and to address gaps in care amid long NHS waiting times and documented gendered out-of-pocket health costs. The company has partnered with brands such as Cult Beauty and provides education sessions for organizations including Channel 4 and Edelman as part of its expansion efforts. Financially, Hertility has raised more than $14 million in total funding to date, including a community-led round last summer that raised around $7.5 million. Investors named in the article include Local Globe, the Sequoia Scout Fund, and a previously undisclosed investment from actress Emma Watson. Hertility’s stated goal is to get more women talking about hormones and fertility and to meet women where they are to change behavior globally. Hertility Health is a UK-based, science-driven women's health network that offers fertility and hormone testing alongside a triage system connecting women with licensed experts and clinics. Its services publish results on a personalized online dashboard with insights into ovarian reserve, menstrual cycle and ovulation, hormone health and fertility red flags. The company has served over 2,000 women and provides personalised care pathways that cover symptom management, egg freezing and IVF. It will use the £4.2m seed funding to expand its product offering (fertility and hormone testing, menopause, miscarriage, postnatal care, PCOS and endometriosis testing), to scale clinical trials aimed at reducing diagnosis time for common reproductive conditions, and to establish a scientific and clinical educational health hub for women. Leadership includes Dr. Natalie Getreu (COO), Dr. Helen O'Neill (CEO) and Deirdre O'Neill (CCO).

Total raised

$6M

Funding rounds

2

Latest round

Seed

Latest activity

Jul 2021